| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Larimar Therapeutics, Inc. (LRMR) has 6 insiders with recent SEC Form 4 filings, including 13 buys and 2 sells. LRMR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 9.54M | $38.25M | - | |
| Dir | 664.8K | $2.67M | - | |
| Dir | 19.0K | $76.2K | - | |
| Dir | 19.0K | $76.2K | - | |
| Dir | 19.0K | $76.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2022 | Flynn James E62 | Director, 10% Owner, * Director By Deputization | Buy | 11,111,108 | $3.15 | $34,999,990.20 | +190.6% | +42.5% | +32.5% | |
| Sep 16, 2022 | Celano Michael72 | Chief Financial Officer | Buy | 31,746 | $3.15 | $99,999.90 | New | +42.5% | +32.5% | |
| Sep 16, 2022 | Ben-Maimon Carole | President And CEO | Buy | 31,746 | $3.15 | $99,999.90 | +126.6% | +42.5% | +32.5% | |
| Sep 16, 2022 | Hamilton Thomas Edward51 | Director | Buy | 317,460 | $3.15 | $999,999.00 | +167.0% | +42.5% | +32.5% | |
| Jun 30, 2021 | Flynn James E62 | Director, 10% Owner, * Director By Deputization | Buy | 685,710 | $8.75 | $5,999,962.50 | +13.3% | +24.7% | -80.0% | |
| Jun 30, 2021 | Hamilton Thomas Edward51 | Director | Buy | 56,710 | $8.75 | $496,212.50 | +42.5% | +24.7% | -80.0% | |
| Jun 28, 2018 | Hughes Thomas E. | See Remarks | Sell | 32,000 | $10.00 | $320,000.00 | -20.4% | - | - | |
| Mar 7, 2018 | Hughes Thomas E. | See Remarks | Sell | 5,000 | $10.00 | $50,000.00 | -3.1% | - | - | |
| Oct 13, 2017 | Heller Frances K | Director | Buy | 10,000 | $3.90 | $38,988.00 | +26.3% | - | - | |
| Jul 11, 2017 | Kim Dennis D | Chief Medical Officer | Buy | 10,000 | $3.39 | $33,900.00 | +87.4% | - | - |